(Q38421751)

English

Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancers

scientific article published on 05 October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancers (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

based on heuristic

inferred from title

object named as

Namshin Kim

11

0 references

Hyeong-Gon Moon

object named as

Hyeong-Gon Moon

1

0 references

15

object named as

Dong-Young Noh

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

13

object named as

Wonshik Han

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

9

object named as

Han Suk Ryu

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

6

object named as

Tae-Kyung Yoo

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

12

object named as

Seongmun Jeong

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Keunhee Oh

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Jiwoo Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Minju Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Ju-Yeon Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Myung Won Seo

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Ae Kyung Park

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Eun-Jung Jung

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Dong-Sup Lee

14

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

5 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

154

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

13-22

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

https://scigraph.springernature.com/pub.10.1007/s10549-015-3585-y

0 references

Understanding the biology of triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Patient-derived xenograft models: an emerging platform for translational cancer research

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Patient-derived breast tumor xenografts facilitating personalized cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Patient-derived tumor xenografts: transforming clinical samples into mouse models

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

A new model of patient tumor-derived breast cancer xenografts for preclinical assays

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Genome remodelling in a basal-like breast cancer metastasis and xenograft

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Breast cancer molecular phenotype and the use of HER2-targeted agents influence the accuracy of breast MRI after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

A clinically relevant gene signature in triple negative and basal-like breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Innate and adaptive immune cells in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3585-Y

21 January 2018

Identifiers

10.1007/S10549-015-3585-Y

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38421751&oldid=1758578751"